High Bone Mineral Density Osteogenesis Imperfecta in a Family with a Novel Pathogenic Variant in COL1A2
- 11 September 2020
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 93 (4), 263-271
- https://doi.org/10.1159/000510463
Abstract
Osteogenesis imperfecta (OI) is a heterogenous group of heritable bone dysplasias characterized by bone fragility, typically low bone mass, joint laxity, easy bruising, and variable short stature. Classical OI is caused by autosomal dominant pathogenic variants in COL1A1 or COL1A2 that result in either reduced production of normal type 1 collagen or structurally abnormal collagen molecules. Pathogenic variants in these genes generally result in low bone mass. Here, we report a family that had 2 affected individuals who presented with minimal trauma fractures and were found to have elevated bone mineral density (BMD) and a previously unreported variant in COL1A2 c.3356C>T p.(Ala1119Val). We report the change in BMD using dual-energy X-ray and peripheral quantitative computed tomography over a 2.3-year period in the proband. This case report highlights the importance of BMD studies and genetic testing in the diagnostic process for brittle bone disorders.Keywords
This publication has 24 references indexed in Scilit:
- COL1A1 C‐propeptide cleavage site mutation causes high bone mass, bone fragility and jaw lesions: a new cause of gnathodiaphyseal dysplasia?Clinical Genetics, 2014
- Osteogenesis Imperfecta: Diagnosis and TreatmentCurrent Osteoporosis Reports, 2014
- Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessmentAmerican Journal of Medical Genetics Part A, 2014
- Hyperosteoidosis and Hypermineralization in the Same Bone: Bone Tissue Analyses in a Boy with a Homozygous BMP1 MutationCalcified Tissue International, 2013
- Intravenous Pamidronate Treatment in Children with Moderate-to-Severe Osteogenesis Imperfecta Started under Three Years of AgeHormone Research in Paediatrics, 2013
- Attenuated BMP1 Function Compromises Osteogenesis, Leading to Bone Fragility in Humans and ZebrafishAmerican Journal of Human Genetics, 2012
- COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfectaHuman Mutation, 2011
- A single amino acid substitution (D1441Y) in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I collagen results in a lethal variant of osteogenesis imperfecta with features of dense bone diseasesJournal of Medical Genetics, 2002
- Bone mineral density of total body, spine, and femoral neck in children and young adults: A cross-sectional and longitudinal studyJournal of Bone and Mineral Research, 1994
- New approaches for interpreting projected bone densitometry dataJournal of Bone and Mineral Research, 1992